Paroxetine
Product Images NDC 63629-9498

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 63629-9498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299498)

Label for Paroxetine Extended-Release Tablets, USP, 12.5 mg by Bryant Ranch Prepack. The label includes product NDC 63629-9498-01, a quantity of 30 tablets, and the designation Rx only. Storage instructions and dispensing information are also present on the label.*

FDA Label Image

Chemical Structure (Paroxetine 01)

Chemical structure of paroxetine hydrochloride showing the arrangement of atoms including a fluorophenyl group, a piperidine ring, and a methylenedioxyphenyl group with associated hydrochloride salt.*

FDA Label Image

Figure 1 (Paroxetine 02)

This chart depicts the fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for various interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to a reference. The x-axis shows the change relative to reference on a logarithmic scale from 0.1 to 10.0.*

FDA Label Image

Figure 2 (Paroxetine 03)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC of paroxetine when co-administered with interacting drugs including Cimetidine 300 mg, Phenobarbital 100 mg, Phenytoin 300 mg, Digoxin 0.25 mg, and Diazepam 5 mg, with fold changes relative to reference plotted on the x-axis from 0 to 2.*

FDA Label Image

Figure 3 (Paroxetine 04)

A pharmacokinetic chart showing fold change and 90% confidence intervals of various parameters (Cmax, Cmin, AUC) relative to reference for populations with renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years with different dose levels, and gender (males). The x-axis is logarithmic, ranging from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.